Resilience: Determinants, measurement, and treatment responsiveness

CNS Spectrums

Volumn 11, Issue SUPPL. 12, 2006, Pages 5-12

  Connor, Kathryn M ^a   Zhang, Wei ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; FLUOXETINE; NORADRENALIN UPTAKE INHIBITOR; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE; SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, HUMAN;

ADAPTIVE BEHAVIOR; ALTRUISM; ANXIETY; ARTICLE; COGNITIVE THERAPY; CONNOR DAVIDSON RESILIENCE SCALE; COPING BEHAVIOR; DEPRESSION; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; HUMOR; MEASUREMENT; MOTIVATION; NEUROBIOLOGY; OPTIMISM; PATIENCE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RATING SCALE; STRESS; TEMPERAMENT; ANXIETY DISORDER; AROUSAL; BEHAVIOR THERAPY; BRAIN; DRUG EFFECT; GENETIC POLYMORPHISM; GENETICS; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW; RISK FACTOR; SOCIAL ENVIRONMENT;

ADAPTATION, PSYCHOLOGICAL; ANXIETY DISORDERS; AROUSAL; BEHAVIOR THERAPY; BRAIN; COMBINED MODALITY THERAPY; HUMANS; MOTIVATION; POLYMORPHISM, GENETIC; RISK FACTORS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; SOCIAL ENVIRONMENT; STRESS DISORDERS, POST-TRAUMATIC; TEMPERAMENT;

EID: 33750335270     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1092852900025797     Document Type: Article

References (45)

1. Richardson GE. The metatheory of resilience and resiliency. J Clin Psychol. 2002;58:307-321.
2. Seligman ME, Csikszentmihalyi M. Positive psychology. An introduction. Am Psychol. 2000;55:5-14.
3. Rutter M. Resilience in the face of adversity. Protective factors and resistance to psychiatric disorder. Br J Psychiatry. 1985;147:598-611.
4. Garmezy N. Stress Resistant Children: The Search for Protective Factors. Recent Research in Developmental Psychopathology. Book supplement no. 4 to J Child Psychol Psych. Oxford: Pergamon Press; 1985.
5. Garmezy N, Rutter M. Acute stress reactions. In: Rutter M, Hersob L, eds. Child and Adolescent Psychology: Modern Approaches. Oxford: Blackwell; 1985.
6. Kobasa SC. Stressful life events, personality, and health: an inquiry into hardiness. J Pers Soc Psychol. 1979;37:1-11.
7. Lyons J. Strategies for assessing the potential for positive adjustment following trauma. J Trauma Stress. 1991;4:93-111.
8. Werner EE. The children of Kauai: resiliency and recovery in adolescence and adulthood. J Adolesc Health. 1992;13:262-268.
9. Richardson GE, Neiger B, Jensen S, Kumpfer K. The resiliency model. Health Educ. 1990;21:33-39.
10. McEwen BS, Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Intern Med. 1993;153:2093-2101.
11. Sterling P, Eyer J, Allostasis: a new paradigm to explain arousal pathology. In: Fisher S, Reason J, eds. Handbook of Life Stress, Cognition, and Health. New York, NY: John Wiley & Sons: 1988:629-649.
12. Seeman TE, McEwen BS, Rowe JW, Singer BH. Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proc Natl Acad Sci U S A. 2001;98:4770-4775.
13. Karlamangla AS, Singer BH, McEwen BS, Rowe JW, Seeman TE. Allostatic load as a predictor of functional decline. MacArthur studies of successful aging. J Clin Epidemiol. 2002;55:696-710.
14. Charney DS. Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am J Psychiatry. 2004;161:195-216.
15. Bale TL, Picetti R, Contarino A, Koob GF, Vale WW, Lee KF. Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J Neurosci. 2002;22:193-199.
16. Baker DG, West SA, Nicholson WE, et al. Serial CSF corticotropin- releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry. 1999;156:585-588.
17. Nemeroff CB. Recent advances in the neurobiology of depression. Psychopharmacol Bull. 2002;36(suppl 2):6-23.
18. Bremner JD, Licinio J, Damell A, et al. Elevated CSF corticotropin- releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry. 1997;154:624-629.
19. Lesch KP, Mossner R. Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? Biol Psychiatry. 1998;44:179-192.
20. Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527-1531.
21. Murphy DL, Li Q, Engel S, et al. Genetic perspectives on the serotonin transporter. Brain Res Bull. 2001;56:487-494.
22. Hariri AR, Mattay VS, Tessitore A et al. Serotonin transporter genetic variation and the response of the human amygdala. Science. 2002;297:400-403.
23. Hamer D. Genetics. Rethinking behavior genetics. Science. 2002;298:71-72.
24. Lesch KP. Neuroticism and serotonin: a developmental genentic perspective. In: Plomin R, DeFries JC, Craig IW, McGuffin P, eds. Behavioral Genetics in the Postgenomics Era. Washington, DC: American Psychiatric Association: 2003:389-424.
25. Caspi A, Sugden K, Moffitt TE et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386-389.
26. Costello EJ, Pine DS, Hammen C et al. Development and natural history of mood disorders. Biol Psychiatry. 2002;52:529-542.
27. Kendler KS, Karkowski LM, Prescott CA. Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry. 1999;156:837-841.
28. Tsuang MT, Faraone SV. The future of psychiatric genetics. Curr Psychiatry Rep. 2000;2:133-136.
29. Kendler KS, Roy MA. Validity of a diagnosis of lifetime major depression obtained by personal interview versus family history. Am J Psychiatry. 1995;152:1608-1614.
30. Tsuang MT. Genes, environment, and mental health wellness. Am J Psychiatry. 2000;157:489-491.
31. Kim-Cohen J, Moffitt TE, Caspi A, Taylor A. Genetic and environmental processes in young children's resilience and vulnerability to socioeconomic deprivation. Child Dev. 2004;75:651-668.
32. Tschann JM, Kaiser P, Chesney MA, Alkon A, Boyce WT. Resilience and vulnerability among preschool children: family functioning, temperament, and behavior problems. J Am Acad Child Adolesc Psychiatry. 1996;35:184-192.
33. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52:1048-1060.
34. Shalev AY. Stress versus traumatic stress: from acute homeostatic reactions to chronic psychopathology. In: van der Kolk BA, McFarlane AC, Weisaeth L, eds. Traumatic Stress. New York, NY: Guilford Press: 1996:77-101.
35. Brewin CR, Andrews B, Valentine JD. Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. J Consult Clin Psychol. 2000;68:748-766.
36. Wagnild GM, Young HM. Development and psychometric evaluation of the Resilience Scale. J Nurs Meas. 1993;1:165-178.
37. Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CO-RISC). Depress Anxiety. 2003;18:76-82.
38. Alexander C. The Endurance: Shackleton's Legendary Antarctic Expedition. London: A. Knopf; 1998.
39. Ravindran AV, Griffiths J, Waddell C, Anisman H. Stressful life events and coping styles in relation to dysthymia and major depressive disorder: variations associated with the alleviation of symptoms following pharmacotherapy Prog Neuro Psychopharmacol Biol Psychiatry. 1995;19:637-653.
40. Healy D, Healy H. The clinical pharmacologic profile of reboxetine: does it involve the putative neurobiological substrates of wellbeing? J Affect Disord. 1998;51:313-322.
41. Connor KM, Sutherland SM, Tupler LA, Malik ML, Davidson JR. Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study. Br J Psychiatry. 1999;175:17-22.
42. Sheehan DV Raj AB, Sheehan KH, Soto S. Is buspirone effective for panic disorder? J Clin Psychopharmacol. 1990;10:3-11.
43. Sheehan DV. The Anxiety Disease. New York, NY: Charles Scribners Sons; 1983.
44. Davidson JR, Payne VM, Connor KM et al. Trauma, resilience and saliostasis: effects of treatment in post-traumatic stress disorder Int Clin Psychopharmacol. 2005:20:43-48.
45. Davidson J, Stein DJ, Rothbaum BO, Pedersen R, Tain XW, Musgnung J. Resilience as a predictor of remission in PTSD patients treated with venlafaxine XR or placebo. Poster presented at: Annual Meeting of the Anxiety Disorders Association of America; March 23-26, 2006; Miami, Florida.